SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009258
Filing Date
2023-05-11
Accepted
2023-05-11 07:14:13
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20230331x10q.htm   iXBRL 10-Q 1287008
2 EX-10.1 hook-20230331xex10d1.htm EX-10.1 108789
3 EX-10.2 hook-20230331xex10d2.htm EX-10.2 114995
4 EX-31.1 hook-20230331xex31d1.htm EX-31.1 9853
5 EX-31.2 hook-20230331xex31d2.htm EX-31.2 9847
6 EX-32.1 hook-20230331xex32d1.htm EX-32.1 8464
  Complete submission text file 0001558370-23-009258.txt   6183041

Data Files

Seq Description Document Type Size
7 EX-101.SCH hook-20230331.xsd EX-101.SCH 54690
8 EX-101.CAL hook-20230331_cal.xml EX-101.CAL 50614
9 EX-101.DEF hook-20230331_def.xml EX-101.DEF 194127
10 EX-101.LAB hook-20230331_lab.xml EX-101.LAB 445039
11 EX-101.PRE hook-20230331_pre.xml EX-101.PRE 327746
64 EXTRACTED XBRL INSTANCE DOCUMENT hook-20230331x10q_htm.xml XML 872187
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 23908793
SIC: 2834 Pharmaceutical Preparations